Analogic — Investor Presentation (January 2017)
33 slides from Analogic's investor presentation, Jan 10, 2017
Slide 1: Investor overview
Investor overview January 11, 2017 Exhibit 99.1
Slide 2: Safe Harbor
Safe Harbor Any statements about future expectations, plans, and prospects for the Company, including statements containing the words “believes,” “anticipates,” “plans,” “expects,” and similar expressions, constitute forward-looking statements within the meaning of the Private Securities Litigation
Slide 3: Use of Non-GAAP Financial Measures
This presentation includes non-GAAP financial measures that are not in accordance with, nor an alternative to, generally accepted accounting principles and may be different from such non-GAAP measures used by other companies. In addition, these non-GAAP measures are not based on any comprehensive se
Slide 4: Investment Thesis
Investment Thesis Our Imaging Technologies in Medical, Ultrasound and Security Markets Create Opportunities Expanding Available Markets Focusing on Execution will Drive Increased Earnings Improving Operating Leverage
Slide 5: Medical and Security Imaging Innovations
Medical and Security Imaging Innovations Founded in 1967 Advancing image guidance technology for medical and security Global research, engineering, and operations Fiscal 2016 Highlights: $509 million revenue $3.54 Non-GAAP* EPS Operating cash of $33 million, Free cash flow** of $20 million 1,600 emp
Slide 6: Our Imaging Technology Drives Innovative Products
Our Imaging Technology Drives Innovative Products Material Science Signal and image processing Precision A/D conversion Precision RF/Power Amplification Imaging & Guidance “Core Technologies” “Critical Imaging Chain” Mammo Ultrasound Probes High voltage power supplies High power amplifiers Pulsed RF
Slide 7: Our Business Segments
Our Business Segments Medical Imaging Ultrasound Security & Detection 57% of revenues 32% of revenues 11% of revenues Increase content with OEMs Leverage common platforms Drive growth in emerging markets Expand share in Urology / Surgery Expand into General Imaging with technology partner Evaluate o
Slide 8: Moving to the Next Level of Performance
Moving to the Next Level of Performance Non-GAAP operating margin and EPS figures exclude certain charges; please refer to the non-GAAP reconciliation table in the back of this presentation. Inconsistent results in recent years requires renewed focus
Slide 9: Focus Drives Improved Shareholder Returns
Focus Drives Improved Shareholder Returns Optimize product portfolio Manage operating expense structure Drive consistent revenue growth Bring discipline to the M&A process
Slide 10: Medical Imaging
Medical Imaging
Slide 11: Guidance in Medical Imaging
Guidance in Medical Imaging Computed Tomography Digital Mammography Magnetic Resonance
Slide 12: Increasing Our Value to OEMs in CT
Increasing Our Value to OEMs in CT Data Acquisition Subsystem Detection Management Subsystem Power & Data Management CT Imaging engine Image Reconfiguration Business growth opportunities with current & new OEMs Historical base business with OEMs
Slide 13: Ruggedized CT Gantry Installations in China
Qinghai Xinjiang Inner Mongolia Tibet Guizhou Zhejiang Fujian Gansu Ningxia Shanxi Shanxi Hebei Heilongjiang Jilin Liaoning Shandong Jiangsu Henan Anhui Hubei Hunan Jiangxi Yunnan Sichuan Chongqing Guangxi Guangdong Ruggedized CT Gantry Installations 1 4 2 11 17 13 1 4 3 9 7 4 11 6 5 12 15 5 6 11 6
Slide 14: Magnetic Resonance Power Sub-systems
Magnetic Resonance Power Sub-systems RF Amplifier Gradient Amplifier Enabled 3T wide bore systems Common platforms and modular design Design wins with new market entrants
Slide 15: Digital Mammography Detector Sub-Systems
Digital Mammography Detector Sub-Systems Analogic Enables Best Detection Superior Se Based Technology Premium 3D tomo performance Lower dose with best image quality Fastest Image acquisition US installed base of 2D is ~ 11,000 systems, more than 5000 are 7+ years Replacement cycle is moving to 3D
Slide 16: Medical Imaging: Stable Performance
Medical Imaging: Stable Performance Revenue base with significant improvement in non-GAAP operating margins Margin improvement driven by product/customer mix and cost initiatives Non-GAAP operating margin and EPS figures exclude certain charges; please refer to the non-GAAP reconciliation table in t
Slide 17: Security and Detection
Security and Detection
Slide 18: Checked Baggage Opportunities with Leading OEMs
Checked Baggage Opportunities with Leading OEMs North America Replacement Demand 1800 sockets TSA extended EDS life from 10 to 15 years to prepare for next gen purchases Canada completing purchases of high-speed EDS systems Europe and Middle East Increasing Momentum 2000 sockets Early adoption under
Slide 19: Checkpoint CT Under Evaluation
Checkpoint CT Under Evaluation ConnectCT accepted into TSA laboratory for formal certification testing; International certification testing in early 2017 Commercial trials with CT in Europe validated a 2X operational improvement with over 1.3 million bags scanned while improving detection ConnectCT
Slide 20: Upside Potential in Rapid DNA
Upside Potential in Rapid DNA DNA profile generated in under 84 minutes vs. weeks in federal labs Significant market opportunity for law enforcement and government agencies FBI NDIS (National DNA Index System) approval achieved for domestic 4-color version Evaluation currently underway for new globa
Slide 21: Security and Detection: Strong Leverage
Security and Detection: Strong Leverage Unpredictable revenue with solid double digit operating margins Growing high speed check baggage market opportunity OUS and stable medium speed in the U.S. Non-GAAP operating margin and EPS figures exclude certain charges; please refer to the non-GAAP reconcil
Slide 22: Ultrasound
ULTRASOUND
Slide 23: Expanding Market Opportunity
Expanding Market Opportunity Global Ultrasound Market 2015, $6.4B Growing Presence Source: IHS Ultrasound Clinical Applications Market Forecasts 2015 1 2 1 POC: Point of care 2 IR: Interventional Radiology Radiology / General Imaging 3.3% Market Segments Technology Partnerships OB/GYN 7.0% Cardiolog
Slide 24: Positioned for Growth in Key Segments
Positioned for Growth in Key Segments *Analogic Patented and Trademarked Technology Surgical Guidance bk5000 Urology bk3000 General Imaging Partnerships Point of Care Anesthesia/EMED Handheld bk3500 Sonic Window Portfolio Optimization
Slide 25: Ultrasound: Key Turnaround Opportunity
Ultrasound: Key Turnaround Opportunity Sales growth has not matched our pace of investment Focus on optimizing portfolio and improving operating profit Investments in POC, Sonic Window, new bk platform, WW sales force and Oncura OEM Probes Non-GAAP operating margin and EPS figures exclude certain ch
Slide 26: Financial Outlook
F SIPINANCIAL =. OUTLOOK
Slide 27: Financial Outlook
Financial Outlook Non-GAAP operating margin and EPS figures exclude certain charges; please refer to the non-GAAP reconciliation table in the back of this presentation. FY 2017 Revenue Outlook: Medical Imaging expected to be roughly flat for the year Security and Detection expected double digit grow
Slide 28: Strong Balance Sheet and Consistent Cash Flows
Strong Balance Sheet and Consistent Cash Flows 1 As of July 31, 2015 Includes $12MM tax refund $142MM1 of Cash/Investments with no long term debt Consistent operating cash flows Capital allocation through ongoing investment, M&A and share re-purchase $15 million share repurchase program in place 1 A
Slide 29: Investment Thesis
Investment Thesis Our Imaging Technologies in Medical, Ultrasound and Security Create Opportunities Expanding Available Markets Focusing on Execution will Drive Increased Earnings Improving Operating Leverage
Slide 30: Appendix
Appendix OVERVIEW
Slide 31: Non-GAAP Reconciliation
Non-Gaap Reconciliation Gi \ OVERVIEW analogic” ‘
Slide 32: Non-GAAP Statements of Operations Reconciliation
NON-GAAP ST’ ME (hn thousands, excopt per share data) GAAP Income From Operation: Rost ‘Acquistion rolated revenues and expenses Non-GAAP Income From Operations Percentage of Total Net Revenue GAAP Other income (Expen: don BK Medical distrbutor mattor inquiry related costs ‘Acquisition rolated reven
Slide 33: Non-GAAP Statements of Operations Reconciliation
NON-GAAP STATEMENTS OF OPERATIONS RECONCILIATION (h thousands, except per share data) ‘Twelve months Ended July 34,2012 July 34,2013 July 31,2014 July 31,2015 July31, 2016 Medical Imaging GAAP Income From Operations Shore sation expense “ax refund related cha GAAP Income From Operations " Percentage